International Journal of Medical & Pharmaceutical Sciences (IJMPS)

IJMPS - 14(08), August, 2024

Pages: 09-14

In Silico Investigations of Fluorine Substituted Chalcones

 

 

Author: Suman Uraiha, Jyoti Maitry, Lata Patel Choudhary, Yogesh Pounikar

Category: Pharmaceutical Sciences

[Download PDF]

Abstract:

Aim: The present study was undertaken to explore the pharmacological potential of Chalcone derivatives through a comprehensive in silico approach. A thorough review of reputed pharmaceutical and biomedical databases such as PubMed and Scopus revealed a significant research gap pertaining to Chalcone molecules, largely due to limited substitutions, synthetic challenges, and their underrepresentation in mainstream medicinal chemistry. Consequently, this study aims to address the vacuum in pharmacodynamics, pharmacokinetics, toxicity, metabolite behavior, and molecular interactions of Chalcones by employing a multi-tool computational analysis.
Methodology: Molecular docking studies were performed using AutoDock Vina to assess the binding efficiency against a specific disease target. Complementary investigations included network pharmacology, molecular simulations, and structure-activity relationship (SAR)-based analyses.
Results: The study successfully identified high-affinity Chalcone derivatives with promising Glide Scores and pharmacokinetic profiles. Target prediction studies revealed potential biological targets with plausible therapeutic relevance. QuikProp analysis indicated that most derivatives adhered to key drug-likeness criteria. Toxicity prediction tools outlined acceptable safety margins for selected molecules, with manageable IC50 and LD50 values. Bioisosteric modification improved pharmacokinetic profiles in select derivatives. Metabolism studies suggested viable biotransformation pathways and potential active metabolites. Interaction studies demonstrated low risk of adverse food or drug interactions, increasing their candidacy as future therapeutic agents.
Conclusion: This research provides a detailed computational insight into the therapeutic promise of Chalcone molecules by employing a wide range of free and accessible in silico tools. The findings not only bridge existing knowledge gaps in Chalcone pharmacology but also offer a practical guide for future experimental validation.

Keywords: Chalcone, In silico, Pharmacokinetics, Toxicity, Computational, Docking

References:

1. Li J, Fu A, Zhang L. An overview of scoring functions used for protein–ligand interactions in molecular docking. Interdiscip Sci Comput Life Sci. 2019;11(2):320–30.
2. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, et al. Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49(21):6177–96.
3. Meng XY, Zhang HX, Mezei M, Cui M. Molecular Docking: A powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011;7(2):146–57.
4. Sliwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods in drug discovery. Pharmacol Rev. 2014;66(1):334–95.
5. Jain AN. Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. J Comput Aided Mol Des. 2007;21(5):281–306.
6. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov. 2004;3(11):935–49.
7. Salmaso V, Moro S. Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview. Front Pharmacol. 2018;9:923.
8. Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function,
efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–61.
9. Huey R, Morris GM, Olson AJ, Goodsell DS. A semiempirical free energy force field with charge-based desolvation. J Comput Chem. 2007;28(6):1145–52.
10. Liu J, Wang R. Classification of current scoring functions. J Chem Inf Model. 2015;55(3):475–82.
11. Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015;20(7):13384–421.
12. Lavecchia A, Di Giovanni C. Virtual screening strategies in drug discovery: A critical review. Curr Med Chem. 2013;20(23):2839–60.